Preneoplastic oral lesions:: The clinical value of image cytometry DNA analysis, p53 and p21/WAF1 expression

被引:0
|
作者
Högmo, A [1 ]
Lindskog, S
Lindholm, J
Kuylenstierna, R
Auer, G
Munck-Wikland, E
机构
[1] Karolinska Hosp, Dept Otorhinolaryngol Head & Neck Surg, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Oral Pathol, Stockholm, Sweden
[3] Karolinska Hosp, Dept Tumour Pathol, S-10401 Stockholm, Sweden
[4] Danderyd Hosp, Dept Tumour Pathol, Stockholm, Sweden
关键词
DNA; p53; p21/WAF1; leukoplakia; mouth neoplasm;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Various mucosal lesions are frequently encountered in the oral cavity. Neither macroscopic nor microscopic evaluation of these lesions gives any reliable information concerning the risk of cancer development. Material and methods: From 21 patients, 29 mucosal lesions were found to precede development of invasive squamous cell carcinoma or carcinoma in situ at the same location. The lesions were matched to 29 control lesions, with the same grade of dysplasia and from exactly the same locations but without subsequent cancer during a mean follow up of 112 months (46-194). The specimens were evaluated using Image Cytometry DNA analysis and immunohistochemical analysis of p53 and p21/WAF1 expression. Results: Lesions prior to carcinomatous development displayed a higher degree of DNA aberration as compared with the control lesions, p53 and p21/WAF1 evaluation did not reveal any differences between cases and controls. Conclusion: Image Cytometry DNA analysis is an useful adjunct to histopathological evaluation of oral mucosal lesions fbr prediction of risk of malignant transformation.
引用
收藏
页码:3645 / 3650
页数:6
相关论文
共 50 条
  • [21] Expression of p53, mdm2, p21/waf1 and bcl-2 proteins in thymomas
    Stefanaki, K
    Rontogianni, D
    Kouvidou, CH
    Bolioti, S
    Delides, G
    Pantelidaki, A
    Sotsiou, F
    Kanavaros, P
    HISTOPATHOLOGY, 1997, 30 (06) : 549 - 555
  • [22] p21 (Waf1/Cip1) expression correlates with disease stage and p53 mutations in colorectal cancer
    Viale, G
    Pellegrini, C
    Mazzarol, G
    Maisonneuve, P
    Silverman, ML
    Bosari, S
    LABORATORY INVESTIGATION, 1997, 76 (01) : 375 - 375
  • [23] Correlation between reduced p21(WAF1/CIP1) expression and abnormal p53 expression in esophageal carcinomas
    Toh, Y
    Kuwano, H
    Sonoda, K
    Saeki, H
    Kawaguchi, H
    KItamura, K
    Nakashima, H
    Sugimachi, K
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 11 (04) : 703 - 708
  • [24] p21(Waf1/cip1) expression
    Rees, JL
    BRITISH JOURNAL OF DERMATOLOGY, 1997, 136 (05) : 803 - 803
  • [25] Expression of p21/waf1 in oral squamous cell carcinomas - correlation with p53 and mdm2 and cellular proliferation index
    Ng, IOL
    Lam, KY
    Ng, M
    Regezi, JA
    ORAL ONCOLOGY, 1999, 35 (01): : 63 - 69
  • [26] p53 expression correlates with apoptosis but not with p21 waf expression in retinoblastomas
    Divan, A
    Webley, K
    Karcioglu, ZA
    Mullaney, P
    Dunsmore, IR
    Rennie, IG
    Parsons, MA
    Royds, JA
    JOURNAL OF PATHOLOGY, 1997, 182 : A6 - A6
  • [27] p53 expression in CMV-infected cells: Association with the alternative expression of the p53 transactivated genes p21/WAF1 and MDM2
    Garcia, JF
    Piris, MA
    Lloret, E
    Orradre, JL
    Murillo, PG
    Martinez, JC
    HISTOPATHOLOGY, 1997, 30 (02) : 120 - 125
  • [28] Expression of p21(WAF1/CIP1) in fetal and adult tissues: simultaneous analysis with Ki67 and p53
    Mateo, MS
    Saez, AI
    SanchezBeato, M
    Garcia, P
    SanchezVerde, L
    Martinez, JC
    Orradre, JL
    Piris, MA
    JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (08) : 645 - 653
  • [29] Significance of P21(WAF-1)(p21) and P53 expression in renal cell carcinoma (RCC).
    Madan, S
    Grignon, D
    Sarkar, F
    Kattar, M
    Yaman, D
    Sakr, W
    Haas, G
    Crissman, J
    LABORATORY INVESTIGATION, 1996, 74 (01) : 443 - 443
  • [30] Cyclin D1 and p21/waf1 are both involved in p53 growth suppression
    DelSal, G
    Murphy, M
    Ruaro, EM
    Lazarevic, D
    Levine, AJ
    Schneider, C
    ONCOGENE, 1996, 12 (01) : 177 - 185